Clinical trial
Open, Multicenter Observational Study of Oxaliplatin Utilized in Combination Therapy for Adjuvant Treatment of Colon Carcinoma of Stage III After Complete Removal of the Primary Tumor and for Treatment of Metastasizing Colorectal Carcinoma.
NCT01942200 is registered in ClinicalTrials.gov with Onkovis GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Multicenter Observational Study of Oxaliplatin Utilized in Combination Therapy for Adjuvant Treatment of Colon Carcinoma of Stage III After Complete Removal of the Primary Tumor and for Treatment of Metastasizing Colorectal Carcinoma.
- Lead sponsor
- Onkovis GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- July 25, 2018
- Enrollment
- 383 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.